Ea. Komarova et Av. Gudkov, Chemoprotection from p53-dependent apoptosis: potential clinical applications of the p53 inhibitors, BIOCH PHARM, 62(6), 2001, pp. 657-667
The p53 tumor suppressor pathway is a key mediator of stress response that
protects the organism from accumulating genetically altered and potentially
cancerous cells by inducing growth arrest or apoptosis in damaged cells. H
owever, under certain stressful conditions, p53 activity can result in mass
ive apoptosis in sensitive tissues, leading to severe pathological conseque
nces for the organism. One such situation is anticancer therapy that is oft
en associated with general genotoxic stress, leading to p53-dependent apopt
osis in the epithelia of the digestive tract and in the hematopoietic syste
m. A chemical inhibitor of p53, capable of suppressing p53-mediated apoptos
is, was shown to protect mice from lethal doses of gamma-radiation, making
pharmacological suppression of p53 a perspective therapeutic approach to re
duce the side-effects of cancer treatment. There are other situations, besi
des anti-cancer therapy, when humans are exposed to stressful conditions kn
own to involve p53 activation, which, in extreme cases, could result in the
development of life-threatening diseases. Here we review the experimental
evidence on the role of p53 in tissue injuries associated with hypoxia (hea
rt and brain ischemias) and hyperthermia (fever and bums), comparing these
pathologies with the consequences of genotoxic stress of cancer treatment.
The accumulated information points to the involvement of p53 in the generat
ion of the pathological outcome of the above stresses, making them potentia
l targets for the therapeutic application of p53 inhibitors. (C) 2001 Elsev
ier Science Inc. All rights reserved.